相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Gabriela Dumitrita Stanciu et al.
BIOMOLECULES (2020)
Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease
Syed Obaidur Rahman et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation
I. Husain et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2018)
Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation
Ronit Shapira et al.
NEUROBIOLOGY OF AGING (2018)
Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism
Madhu Kaundal et al.
PHARMACOLOGICAL REPORTS (2018)
Linagliptin potentiates the effect of L-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-beta 1, NF-kappa B and glucagon-like peptide 1
Ahmed M. Kabel et al.
PHYSIOLOGY & BEHAVIOR (2018)
Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
Christian Benedict et al.
FRONTIERS IN NEUROSCIENCE (2018)
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology
Antonella Tramutola et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease
Jayasankar Kosaraju et al.
MOLECULAR NEUROBIOLOGY (2017)
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology
Antonella Tramutola et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Investigation of thymol effect on learning and memory impairment induced by intrahippocampal injection of amyloid beta peptide in high fat diet- fed rats
Masoumeh Asadbegi et al.
METABOLIC BRAIN DISEASE (2017)
Rosuvastatin Attenuates High-Salt and Cholesterol Diet Induced Neuroinflammation and Cognitive Impairment via Preventing Nuclear Factor KappaB Pathway
Ibraheem Husain et al.
NEUROCHEMICAL RESEARCH (2017)
N-truncated Aβ4-x peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse models
Oliver Wirths et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease
Ghada A. Badawi et al.
INFLAMMOPHARMACOLOGY (2017)
Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Francesca Regen et al.
CURRENT ALZHEIMER RESEARCH (2017)
N-acetylcysteine protects memory decline induced by streptozotocin in mice
Michael Costa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor
V. Darsalia et al.
DIABETES OBESITY & METABOLISM (2016)
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
Mudasir Maqbool et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior
Sheetal Sharma et al.
NEUROLOGICAL RESEARCH (2016)
Therapeutic strategies for Alzheimer's disease in clinical trials
Justyna Godyn et al.
PHARMACOLOGICAL REPORTS (2016)
Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist
Kenichi Katsurada et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid β-induced impairment of learning and memory in rats
Qin Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
Edy Kornelius et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function
Ling Wei et al.
FITOTERAPIA (2015)
Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease
Anand Kamal Sachdeva et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats
Arokiasamy Justin Thenmozhi et al.
NEUROCHEMICAL RESEARCH (2015)
Saxagliptin: A novel antiparkinsonian approach
Noha N. Nassar et al.
NEUROPHARMACOLOGY (2015)
Increased Interaction With Insulin Receptor Substrate 1, a Novel Abnormality in Insulin Resistance and Type 2 Diabetes
Michael Caruso et al.
DIABETES (2014)
Neuroprotective study of Nigella sativa-loaded oral provesicular lipid formulation: in vitro and ex vivo study
Mohd. Akhtar et al.
DRUG DELIVERY (2014)
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice
Vladimer Darsalia et al.
REGULATORY PEPTIDES (2014)
Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease
Enrique Blazquez et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs
Konrad Talbot
NEURODEGENERATIVE DISEASE MANAGEMENT (2014)
DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
Richard P. Shannon
DIABETES (2013)
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy
Qin Zhihui
FUTURE MEDICINAL CHEMISTRY (2013)
A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats
Shivika Rai et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
Jayasankar Kosaraju et al.
NEUROPHARMACOLOGY (2013)
MOLECULAR LINKS BETWEEN ALZHEIMER'S DISEASE AND DIABETES MELLITUS
Y. Yang et al.
NEUROSCIENCE (2013)
Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1-42) rat model of Alzheimer's disease
Oana Cioanca et al.
PHYSIOLOGY & BEHAVIOR (2013)
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4
Song Chen et al.
AGE (2012)
Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit
Mary D. Naylor et al.
ALZHEIMERS & DEMENTIA (2012)
Pharmacology, Efficacy, and Safety of Linagliptin for the Treatment of Type 2 Diabetes Mellitus
Joshua J. Neumiller
ANNALS OF PHARMACOTHERAPY (2012)
Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice
Emilie Faivre et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
Simon Gengler et al.
NEUROBIOLOGY OF AGING (2012)
Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis
Domenico Bosco et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis
Emilie Faivre et al.
JOURNAL OF NEUROPHYSIOLOGY (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
GSK3: A possible link between beta amyloid peptide and tau protein
Felix Hernandez et al.
EXPERIMENTAL NEUROLOGY (2010)
Neuroinflammatory processes in Alzheimer's disease
Michael T. Heneka et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Qiu-Lan Ma et al.
JOURNAL OF NEUROSCIENCE (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease
Hou De-ren et al.
CHINESE MEDICAL JOURNAL (2008)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity
D Puzzo et al.
JOURNAL OF NEUROSCIENCE (2005)
Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation
J Nyberg et al.
JOURNAL OF NEUROSCIENCE (2005)
High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex
XC Zhang et al.
EXPERIMENTAL NEUROLOGY (2005)
Insulin and neurodegenerative disease: shared and specific mechanisms
S Craft et al.
LANCET NEUROLOGY (2004)
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
AJ Kastin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
分享论文
